Streetbeat News

Stock Prices

BALL

Ball Corporation (NYSE:BALL) has significantly outperformed the market over the past 20 years, delivering an average annual return of 10.99%. A $1000 investment in BALL 20 years ago would be worth $8,060.05 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 7:00 pm

BBY

Best Buy Co (NYSE:BBY) has outperformed the market over the past 10 years with an average annual return of 11.87%, resulting in a $1000 investment growing to $3,001.02. The company currently has a market capitalization of $19.15 billion.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 7:00 pm

FETUSD

Fetch.ai (CRYPTO: FET) has seen a price decrease of 3.09% in the past 24 hours, continuing a week-long downward trend of 7.0%. Trading volume has dropped 37.0% over the past week, while the circulating supply has increased slightly by 0.22%. The current market cap is $5.24 billion, ranking it #28.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 7:00 pm

SCLX

Scilex Holding Company has received FDA approval for the commercial manufacturing of Gloperba, a liquid oral version of colchicine for the prophylaxis of gout flares in adults. The product is set to launch on June 10, 2024. Gloperba targets a significant unmet need in the gout treatment market, which is projected to reach $2.0 billion in the U.S. by 2028. Scilex is well-positioned for the launch, leveraging its existing distribution network and experienced commercial team.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 6:57 pm

FFIE

Faraday Future Intelligent Electric (FFIE) has completed the production and testing of its 12th FF 91 2.0 vehicle, which is set to be delivered to its first retail investor user. The company's CPO shared this update on X, along with two special videos introducing the new car to the user.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 6:50 pm

CVX

Deep-pocketed investors are showing unusual options activity in Chevron (NYSE:CVX), with a significant number of bullish and bearish trades. The options activity suggests a potential price range of $135.0 to $180.0 for CVX. Analysts have mixed ratings, with target prices ranging from $166 to $205.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 6:46 pm

ASNS

FRGT

ICU

REPL

SJM

VNDA

VTYX

U.S. stocks traded mixed with the S&P 500 falling 0.1%. J. M. Smucker shares surged 5% after beating earnings estimates. Replimune Group, Vanda Pharmaceuticals, and Freight Technologies saw significant gains, while Actelis Networks, SeaStar Medical, and Ventyx Biosciences experienced sharp declines.

Portfolio Pulse from Avi Kapoor

June 06, 2024 | 6:45 pm

GME

HOOD

Robinhood CEO Vlad Tenev is set to discuss GameStop on Fox Business at 3:30 PM EST, ahead of a Roaring Kitty YouTube livestream on Friday.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 6:41 pm

NIO

Nio Inc. (NYSE:NIO) missed Q1 2024 earnings expectations, leading to a 6.5% stock decline. Despite a 39.9% drop in vehicle deliveries and a 42.1% revenue decline from the previous quarter, expert Anthony Sassine from KraneShares remains optimistic about Nio's future due to model upgrades, new launches, and improved margins. Nio's Q2 guidance suggests a potential recovery.

Portfolio Pulse from Surbhi Jain

June 06, 2024 | 6:37 pm

NRG

NRG Energy has seen a significant surge in options activity, with a majority of trades showing bearish sentiment. The stock is currently trading at $77.6, down by 4.84%. Analysts have mixed ratings with target prices ranging from $82 to $110.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 6:31 pm